What does offering costs, partnership interests mean?

Represents the total costs incurred by the company associated with the issuance and offering of partnership interests or equity securities. These costs are typically deferred and amortized over the life of the offering or recognized as a reduction of equity. Monitoring these costs is essential for assessing the efficiency of capital raising activities.

Golub Capital GBDC Offering costs, partnership interests

Offering costs, partnership interests at other companies

Rapport Therapeutics, Inc.RAPP

$180K—

Cal-Maine FoodsCALM

$1.7M—

ImmunomeIMNM

$364K-96.5%

Tarsus Pharmaceuticals, Inc.TARS

$0-100%

Dyne Therapeutics, Inc.DYN

$106K—

Arteris, Inc.AIP

$296K—

Other financials

Income statement

See full

Net income-$46.8M-159%

EPS (diluted)-$0.18-160%

Balance sheet

See full

Cash & equivalents$135.2M-45.1%

Total debt$4.7B-2.2%

Total equity$3.7B-7.3%

Total assets$8.5B-4.7%

Cash flow

See full

Operating cash flow$248.8M—

Valuation

See full

Market cap$3.21B-17.1%

Returns & leverage

See full

Return on equity5.3%-3.6pp

Debt / equity1.3×+0.1×

Where this comes from

Reported directly by Golub Capital in its filing.

Tagged under the XBRL concept gbdc:SaleOfStockMaximumOfferingPrice.

The official record: Golub Capital’s 10-K, filed November 18, 2025, on SEC EDGAR. View the filing →

Ask your AI about Golub Capital's offering costs, partnership interests.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Golub Capital's offering costs, partnership interests?: Golub Capital (GBDC) reported offering costs, partnership interests of $288.04M in Q2 2025.
What does offering costs, partnership interests mean?: Represents the total costs incurred by the company associated with the issuance and offering of partnership interests or equity securities. These costs are typically deferred and amortized over the life of the offering or recognized as a reduction of equity. Monitoring these costs is essential for assessing the efficiency of capital raising activities.